Outlook Therapeutics Inc (OTLK)
8.51
-0.41
(-4.60%)
USD |
NASDAQ |
May 01, 16:00
8.51
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics Total Return Price: 8.51 for May 1, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 30, 2024 | 8.92 |
| April 29, 2024 | 9.10 |
| April 26, 2024 | 8.43 |
| April 25, 2024 | 8.19 |
| April 24, 2024 | 8.20 |
| April 23, 2024 | 8.20 |
| April 22, 2024 | 8.09 |
| April 19, 2024 | 8.17 |
| April 18, 2024 | 8.29 |
| April 17, 2024 | 8.61 |
| April 16, 2024 | 8.75 |
| April 15, 2024 | 8.62 |
| April 12, 2024 | 8.70 |
| April 11, 2024 | 9.04 |
| April 10, 2024 | 8.99 |
| April 09, 2024 | 9.26 |
| April 08, 2024 | 9.35 |
| April 05, 2024 | 9.26 |
| April 04, 2024 | 9.52 |
| April 03, 2024 | 9.12 |
| April 02, 2024 | 9.70 |
| April 01, 2024 | 10.26 |
| March 28, 2024 | 11.94 |
| March 27, 2024 | 9.37 |
| March 26, 2024 | 8.68 |
| Date | Value |
|---|---|
| March 25, 2024 | 8.51 |
| March 22, 2024 | 8.63 |
| March 21, 2024 | 7.04 |
| March 20, 2024 | 6.78 |
| March 19, 2024 | 7.405 |
| March 18, 2024 | 7.785 |
| March 15, 2024 | 8.24 |
| March 14, 2024 | 5.73 |
| March 13, 2024 | 6.462 |
| March 12, 2024 | 6.992 |
| March 11, 2024 | 7.818 |
| March 08, 2024 | 7.904 |
| March 07, 2024 | 8.226 |
| March 06, 2024 | 8.10 |
| March 05, 2024 | 7.916 |
| March 04, 2024 | 8.452 |
| March 01, 2024 | 8.126 |
| February 29, 2024 | 8.736 |
| February 28, 2024 | 8.75 |
| February 27, 2024 | 8.858 |
| February 26, 2024 | 8.96 |
| February 23, 2024 | 8.772 |
| February 22, 2024 | 8.582 |
| February 21, 2024 | 8.36 |
| February 20, 2024 | 8.678 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
4.072
Minimum
Sep 08 2023
66.20
Maximum
Feb 08 2021
26.53
Average
24.60
Median
Dec 05 2019
Total Return Price Benchmarks
| Cutera Inc | 2.455 |
| Actinium Pharmaceuticals Inc | 7.80 |
| GT Biopharma Inc | 3.17 |
| Karyopharm Therapeutics Inc | 1.085 |
| Marinus Pharmaceuticals Inc | 1.46 |